<bill session="116" type="s" number="1785" updated="2022-11-01T07:02:34Z">
  <state datetime="2019-06-11">REFERRED</state>
  <status>
    <introduced datetime="2019-06-11"/>
  </status>
  <introduced datetime="2019-06-11"/>
  <titles>
    <title type="display">Fair AMP Act</title>
    <title type="short" as="introduced">Fair AMP Act</title>
    <title type="short" as="introduced">Fair and Accurate Medicaid Pricing Act of 2019</title>
    <title type="official" as="introduced">A bill to amend title XIX of the Social Security Act to exclude authorized generic drugs from calculation of the average manufacturer price for purposes of the Medicaid drug rebate program, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="H001076"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2019-06-11"/>
    <cosponsor bioguide_id="C001075" joined="2019-06-11"/>
    <cosponsor bioguide_id="C001056" joined="2019-06-11"/>
    <cosponsor bioguide_id="S000770" joined="2019-06-11"/>
    <cosponsor bioguide_id="Y000064" joined="2019-06-11"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-11">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-06-11" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="4378" relation="unknown"/>
    <bill session="116" type="h" number="3276" relation="identical"/>
    <bill session="116" type="s" number="1801" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Health care costs and insurance"/>
    <term name="Health programs administration and funding"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2019-12-11T15:29:18Z" status="Introduced in Senate">Fair and Accurate Medicaid Pricing Act of 2019 or the Fair AMP Act

This bill alters certain requirements and definitions under the Medicaid Drug Rebate Program relating to rebate calculations. Specifically, the bill repeals the requirement that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations.</summary>
</bill>
